Tag: institutional corruption in medicine and psychiatry

A medical journal is expected to promote an open-minded discussion of treatments, even if findings—or criticisms—threaten conventional beliefs. But the American Journal of Psychiatry will not find space for criticism even if it comes from one of the best-known psychiatrists in the world.

The BMJ reports that renewed concerns about the “revolving door” between government and industry have been sparked by the health minister of England’s decision to join to drug company Roche.